In the Original Investigation titled “Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial,”1 published online on January 22, 2020, there was an error in the Conflict of Interest Disclosures section. The Conflict of Interest Disclosures have been updated to add grants from Axsome Therapeutics and Reveal Biosensors and personal fees from Adare, Millennium Pharmaceuticals, Pernix, and Otsuka Pharmaceutical for Dr Krystal. Dr Krystal has written a Letter2 explaining the omission. This article was corrected online.
References
- 1.Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry. Published online January 22, 2020. doi: 10.1001/jamapsychiatry.2019.4491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Krystal AD. Omitted conflict of interest disclosures. JAMA Psychiatry. Published online April 22, 2020. doi: 10.1001/jamapsychiatry.2020.0616 [DOI] [PubMed] [Google Scholar]